Atypical Hemolytic Uremic Syndrome (aHUS) is a rare but serious condition characterized by the triad of hemolytic anemia, thrombocytopenia (low platelet count), and acute kidney injury.

Days ago, Ryker McCracken was busy playing, like any other 3-year-old. But now he's in the hospital with a life-threatening ...

An Avon family is begging the U.S. Food and Drug Administration for answers after their 10-year-old nearly died from E. coli.

The decision comes amid the rising GBS cases in Pune and Pimpri Chinchwad, where patients are increasingly requiring ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH),atypical hemolytic uremic ...

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

Bangalore: AstraZeneca Pharma India Limited has received permission to import pharmaceutical formulations of new drug for ...